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Research
Polybrominated diphenyl ethers (PBDEs) 
are a group of flame-retardant chemicals 
added to synthetic polymers. The main con-
cern about PBDE health effects in the general 
population relates to prenatal and neonatal 
exposure. Indeed, because of the high lipo-
philicity of PBDEs and their long half-life in 
human tissues (Geyer et al. 2004), even small 
daily exposure throughout life leads to sub-
stantial PBDE accumulation in tissues with 
high lipid content (Johnson-Restrepo et al. 
2005). Animal experiments and human evi-
dence indicate that PBDE probably mobilizes 
during pregnancy, increasing the exposure of 
the developing organism via cord blood and 
then via milk (Antignac et al. 2008; Schecter 
et al. 2006). Moreover, children are exposed 
postnatally to higher PBDE doses because of 
higher rates of dust ingestion (Wilford et al. 
2005) and higher food intake per kilogram of 
body weight (BW) (Schecter et al. 2006). 
Experiments with animal models have 
shown that PBDE exposure interferes with 
developmental processes, causing endocrine 
(Darnerud 2008; Zhou et al. 2001), repro-
ductive (Kuriyama et al. 2005; Lilienthal 
et al. 2006; Talsness et al. 2008), and neuro-
developmental disruption (Kuriyama et al. 
2005; Suvorov et al. 2008; Viberg et al. 
2006). Few articles demonstrate a relationship 
between PBDE exposure and health outcomes 
in the general population (Lim et al. 2008; 
Main et al. 2007).
In spite of the significant number of experi-
mental studies, the mechanisms of PBDE 
toxicity and the most susceptible end points 
remain largely unknown. The history of stud-
ies on another group of persistent and bio-
accumulative organohalogens, polychlorinated 
biphenyls, shows that the mechanisms involved 
could be multiple and remain unclear despite 
the long period of intensive research with tra-
ditional methods (Suvorov and Takser 2008b). 
The rapidly developing “omics” technologies 
provide toxicology with high-throughput 
methods of screening for the molecular targets 
of toxicants (Henry et al. 2002) and could be 
used as the first step in studying emerging envi-
ronmental contaminants. The development 
of the high-throughput screening approach 
corresponds to a major strategic shift in how 
government agencies assess chemical hazards 
and risks (Collins et al. 2008). 
To our knowledge, full-genome gene 
expression microarrays have not been used to 
study PBDE toxicity in a developing mam-
mal. In this study, we analyze the change in 
the global gene expression in liver tissue of 
rat offspring exposed prenatally to 2,2´,4,4´-
tetrabromodiphenyl ether (BDE-47), which 
is the most prevalent PBDE congener found 
in maternal milk (Schecter et al. 2003) and 
cord blood (Mazdai et al. 2003).
Material and Methods
Animals and treatment. We obtained nine 
timed pregnant Wistar rats (250–300 g; 
Charles River Laboratories, St. Constant, 
Québec, Canada) on gestational day (GD) 
14 and housed them in single plastic cages 
with a bedding of sawdust under regulated 
temperature (21 ± 2°C), relative humidity 
(50 ± 10%), and a 12-hr light/dark cycle. 
Food (Charles River Rodent chow 5075) and 
water were provided ad libitum. All animals 
received care in compliance with The Guide 
to the Care and Use of Experimental Animals 
(Canadian Council of Animal Care 1993), 
and the protocol was approved by our institu-
tional animal research ethics review board.
We used the same protocol of exposure as 
in our previous study (Suvorov et al. 2008). In 
short, dams received intravenous caudal injec-
tions of BDE-47 (Chromatographic Specialties 
Inc., Brockville, Ontario, Canada) at doses 
of 0.002 (group 2; G2) and 0.2 mg/kg BW 
(group 3; G3) in 0.3 ml/kg BW of vehicle: 
ethanol 95%, Cremophor EL, and sterile water 
for injections (1:1:8, v/v) from GD15 to post-
natal day (PND) 20 every 5 days (a total of six 
injections/dam). The vehicle was administered 
to control dams (group 1; G1) according to 
the same protocol. 
RNA preparation and microarray analysis. 
One male and one female pup were selected 
randomly per litter on PND 27 and sacrificed 
by decapitation. Whole livers were harvested 
from these pups, snap-frozen in liquid nitro-
gen, and stored at –80°C until RNA extraction. 
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Ba c k g r o u n d: Polybrominated diphenyl ethers are a group of flame-retardant chemicals appearing 
increasingly in the environment. Their health effects and mechanisms of toxicity are poorly understood.
oB j e c t i v e s: We screened for the sensitive effects and mechanisms of toxicity of 2,2´,4,4´-tetra-
bromodiphenyl ether (BDE-47) by analyzing the gene expression profile in rats exposed to doses 
comparable to human exposure.
Me t h o d s : Wistar dams were exposed to vehicle or BDE-47 (0.002 and 0.2 mg/kg body weight) 
every fifth day from gestation day 15 to postnatal day 20 by injections to caudal vein. Total RNA 
was extracted from the livers of pups and hybridized to the whole-genome RNA expression micro-
arrays. The list of genes 2-fold differentially expressed was exported to PANTHER and Ingenuity 
Systems for analysis of enriched ontology groups and molecular pathways.
re s u l t s: Oxidoreductase and transferase protein families were enriched in exposed rats as were 
these biological process categories: carbohydrate metabolism; electron transport; and lipid, fatty 
acid, and steroid metabolism. Four signaling pathways (cascades of activation of drug-metabolizing 
enzymes) and 10 metabolic pathways were significantly enriched. Drug-metabolizing enzymes 
appear to be regulated by BDE-47 through an aryl hydrocarbon receptor–independent mechanism. 
Direct interaction with retinoid X receptor or its upstream cascade may be involved. The main 
metabolic effects consisted of activation of metabolic pathways: α- and ω-oxidation of fatty acids, 
glycolysis, and starch hydrolysis. 
co n c l u s i o n s: Altered expression of genes involved in metabolic and signaling pathways and func-
tions of the organism occurs after perinatal exposure of rat offspring to BDE-47 at doses relevant for 
the general population.
key w o r d s : genomics, low dose, metabolic pathways, microarray, PBDE, P450. Environ Health 
Perspect 118:97–102 (2010).  doi:10.1289/ehp.0901031 available via http://dx.doi.org/ [Online 
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RNA was extracted with the RNeasy Mini Kit 
(Qiagen, Valencia, CA, USA) according to the 
manufacturer’s instructions.
RNA samples were processed for hybridiza-
tion by the Functional Genomics Platform, a 
collaboration between McGill University and 
Genome Quebec Innovation Centre (McGill 
University, Montreal, Canada). RNA and 
cRNA quality control was performed with the 
Agilent (Agilent, Santa Clara, CA, USA) bioan-
alyzer. cRNA was prepared using the Illumina 
RNA amplification kit (Ambion, Austin, 
TX, USA). cRNA was biotynilated during 
the in vitro transcription reaction. cRNA was 
then hybridized to the whole-  genome RNA 
expression BeadChips RatRef-12 (Illumina 
Inc., San Diego, CA, USA) containing 22,523 
50-mer probes. The chips were scanned with 
the Illumina BeadArray Reader.
Data analysis. Data were analyzed using 
FlexArray 1.2 software (Blazejczyk et al. 
2007). The row data were preprocessed and 
normalized with the lumi Bioconductor pack-
age (Du et al. 2007).
The expression values in log2 scale were 
analyzed with ANOVA, followed by a two-
sample Bayesian t-test (Fox and Dimmic 
2006) to identify differentially expressed 
genes. The false discovery rate (FDR) approach 
(Benjamini and Hochberg 1995) was used to 
correct for multiple testing. The list of genes 
2-fold over- or underexpressed significantly 
(p ≤ 0.05; FDR corrected) was generated.
A two-sample Bayesian t-test with the 
FDR correction was run first to compare gene 
expression in male and female offspring. No 
differentially expressed genes (p ≤ 0.05) were 
observed; female and male data were pooled 
within exposure groups for subsequent analysis. 
qRT-PCR. Quantitative real-time poly-
merization chain reaction (qRT-PCR) was 
performed to quantify gene expression to vali-
date the gene expression data obtained from 
microarray analysis (Table 1). Total RNA were 
reverse transcribed using Oligo(dT)15 Primer 
(Promega, Madison, WI, USA) in the presence 
of Omniscript Reverse Transcriptase accord-
ing to the Qiagen protocol (Omniscript RT 
kit; Qiagen). qRT-PCR was carried out with 
the Eppendorf RealPlex System (Eppendorf, 
Hamburg, Germany) according to the protocol 
for the TAKARA SYBR Green kit. All samples 
were run in triplicate reactions. Relative gene 
expression was analyzed according to the 2-ΔΔCt 
method (Livak and Schmittgen 2001). The 
housekeeping gene phosphofructo  kinase was 
used for normalization of the expression data. 
All the primers were designed using Primer-
BLAST software (http://www.ncbi.nlm.nih.
gov/tools/primer-blast/) and the Refseq RNA 
database [National Center for Biotechnology 
Information (NCBI) 2009a], and purchased 
from Integrated DNA Technologies, Inc. 
(Coralville, IA, USA).
Gene ontology and pathway analysis. 
The lists of genes expressed differently in 
response to BDE-47 exposure were imported 
into PANTHER (http://www.pantherdb.
org/), and the number of genes in each func-
tional classification category was compared 
against the number of genes from NCBI’s 
Rattus norvegicus genome (NCBI 2009b) in 
that category. The binomial test was used 
to statistically determine overrepresenta-
tion of PANTHER classification categories. 
Bonferroni-corrected p-values < 0.05 were 
considered significant. 
The same sets of genes were also imported 
into Ingenuity Pathway Analysis (IPA) 
(Ingenuity Systems Inc., Redwood City, CA, 
USA). Canonical pathway analysis identified 
canonical pathways from the IPA library that 
were most significant to the data set. The sig-
nificance of the association between the data set 
and the canonical pathway was measured in two 
ways. First, a ratio of the number of genes from 
the data set that map to the pathway divided 
by the total number of genes that map to the 
canonical pathway was determined. Second, 
Fischer’s exact test, followed by Benjamini–
Hochberg (BH) multiple testing correction, 
was used to calculate a p-value determining the 
probability that the association between the 
genes in the data set and the canonical pathway 
can be accounted for by chance only.
Blood cholesterol and triglycerides 
analysis. Cholesterol and triglycerides were 
determined in trunk blood of pups sacri-
ficed on PND 27. Analysis was performed 
at the Centre Hospitalier Universitaire de 
Sherbrooke (CHUS) Clinical Laboratory by 
Vitros 950 Chemistry System (Ortho-Clinical 
Diagnostics, Rochester, NY, USA). 
Results
We found no significant relationship between 
litter size and dose of exposure to BDE-47, 
with the number of pups varying from 10 
to 17 per litter. No weight differences were 
observed between the control and exposed 
dams throughout the experiment. The BW 
of pups from both exposed groups increased; 
this finding is described in detail elsewhere 
(Suvorov et al. 2009).
Gene expression profile. Sixty genes were 
2-fold differentially expressed (p ≤ 0.05; 
FDR corrected) in livers of the G3 rats [see 
Supplemental Material, Table 1, available online 
(doi:10.1289/ehp.0901031.S1 via http://dx.doi.
org/)]: 22 were under  expressed and 38 were 
overexpressed. Twenty-one genes were 2-fold 
differentially expressed (p ≤ 0.05; FDR cor-
rected) in G2: 3 were under  expressed and 18 
were overexpressed. Monotonic dose–response 
relationships were observed for most of the genes 
2-fold differentially expressed in both groups 
(Figure 1). The response of 6 genes appears to 
be nonlinear: 1 gene (LOC287167) was under-
expressed, and 5 (SLC3A2, LOC497779, 
CYP2C7, LOC292539, PLDN_PREDICTED) 
were overexpressed in G2, whereas their expres-
sion in G3 was not significantly different from 
the control. Expression of 12 genes selected 
randomly was validated by qRT-PCR. A high 
Table 1. Gene expression changes verified by qRT-PCR.
Expression fold-change (log2)  
Illumina qRT-PCR Sequence of primers
Gene ID G2a G3b G2a G3b used in qRT-PCR
AKR1B7 –1.48 –2.02 –1.36 –1.93 TAAGCCTGAGGACCCCGTAG (F)
CACGTTCCTTTGGACATGGA (R)
POR –0.51 –1.39 –0.46 –1.20 ATCACCAACATGGGGGACTC (F)
ACAGAACCATGTCCGTCGTG (R)
PER2 –1.05 –1.36 –1.21 –1.18 GCGGAAATGAAAACTGCTCC (F)
CGATTCCACTAACATCCGCA (R)
CYP7A1 0.05 –1.29 0.13 –1.34 CGCGACAATATGTCCTGGAA (F)
GGGGACACTTGACTTGGCTC (R)
SLC3A2 1.03 0.63 1.00 0.49 GGACACCGAAGTGGACATGA (F)
CACCAGACCGTTCTTCTCCC (R)
IGFBP2 0.48 1.02 0.62 1.17 TTACGCTGTTACCCCAACCC (F)
CACGCGTCTCTTTTCACAGG (R)
CYP2C 0.49 1.05 0.35 1.30 AGGAAAAGCACAATCCGCAG (F)
TTTCAGCAGCAGCAGGAGTC (R)
CLDN1 0.65 1.11 0.55 1.25 GGCTATGAGGGTCTTGGCTG (F)
TCGCCCATTTGAGTGTCATC (R)
RHOA 0.57 1.22 0.71 1.41 CAAGGACCAGTTCCCAGAGG (F)
CCAACTCTACCTGCTTCCCG (R)
CYP3A23 1.22 1.48 1.10 1.68 GAAAGGCAAACCTGTCCCTG (F)
GGATCCTTCGGGTTGTTGAG (R)
G6PC 1.52 1.50 1.65 1.63 CTACACCCTTTGCCAGCCTC (F)
TTGCAGCTCTTGCGGTACAT (R)
INSIG2 1.09 1.55 1.01 1.48 TGGCCCCTACATTTCCTCTG (F)
CAGGAACACGCCAATGAAGA (R)
Abbreviations: F, forward; R, reverse. 
aGroup exposed to 0.002 mg/kg BW BDE-47. bGroup exposed to 0.2 mg/kg BW BDE-47. Gene expression analysis in rats exposed to BDE-47
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correlation was observed between PCR and 
microarray data (Table 1).
PANTHER gene ontology analysis. Among 
molecular functions, the oxidoreductase pro-
tein family with oxygenase subfamily was 
enriched (p ≤ 0.05, Bonferroni corrected) 
in the livers of both groups of exposed rats 
(Table 2). The transferase family was signifi-
cantly overrepresented in G3, and a similar 
trend was characteristic for G2.
These PANTHER biological process cate-
gories were enriched in both exposed groups 
(Table 2): carbohydrate metabolism; electron 
transport; and lipid, fatty acid, and steroid 
metabolism. Within the limits of the last cate-
gory, fatty acid and steroid metabolism were 
significantly overrepresented. Steroid-hormone 
metabolism was overrepresented within the 
limits of steroid metabolism category. The 
enrichment of carbohydrate metabolism and 
steroid-hormone metabolism in G2 was not 
significant but followed the same trend.
Ingenuity Pathway Analysis. We then used 
IPA to perform pathway analysis of the dif-
ferentially expressed gene sets. Of the data set 
of 66 differentially expressed genes, 59 were 
mapped in Ingenuity Knowledge Base; 27 genes 
populated the functions/pathways category. 
Fourteen canonical pathways were sig-
nificantly enriched in the liver samples 
obtained from G2 and G3 (Table 3): 4 sig-
naling pathways dealing mainly with activa-
tion of drug metabolizing enzyme cascade; 
10 metabolic pathways including 4 pathways 
of lipid metabolism, 2 pathways of amino 
acid metabolism, 2 pathways of carbohy-
drate metabolism, 1 pathway of cofactor 
and vitamin metabolism, and 1 pathway of 
complex carbohydrate metabolism. Number 
of pathways were enriched because the 
same differentially expressed genes popu-
lated multiple pathways. The optimized 
set of pathways obtained after exclusion of 
most of overlapping pathways is shown in 
Figure 2 [see also Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0901031.S1)]. 
Blood cholesterol and triglycerides. No sig-
nificant difference was observed in triglycer-
ides blood level in control and exposed pups 
on PND 27 (data not shown). Blood level of 
total cholesterol in G3 (adjusted for litter size, 
individual weight, and sex) was significantly 
higher than in G1. No significant differences 
were observed between G1 and G2. Blood 
cholesterol coincided with underexpression of 
CYP7A1 in the same rats (Figure 3). 
Figure 1. Expression of 66 genes in the livers of the control group and two groups of rats perinatally exposed to 0.2 and 0.002 mg/kg BW of BDE-47. The genes 
illustrated were 2-fold differentially expressed (p ≤ 0.05; FDR corrected) in either exposed group.
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Table 2. Gene ontology analysis using PANTHER.
Molecular function
0.002 mg/kg BW BDE-47 0.2 mg/kg BW BDE-47
No. of genes p-Valuea No. of genes p-Valuea
Transferase 3 9.07 × 10–5 9 5.86 × 10–3
Oxidoreductase 7 2.16 × 10–5 13 2.21 × 10–7
Oxygenase 5 1.80 × 10–5 6 2.65 × 10–4
Biological process
Carbohydrate metabolism 3 3.00 × 10–1 8 1.59 × 10–3
Electron transport 5 1.38 × 10–4 7 3.23 × 10–4
Lipid, fatty acid, and steroid metabolism 9 1.28 × 10–7 12 9.37 × 10–6
Fatty acid metabolism 6 1.55 × 10–6 5 1.86 × 10–2
Steroid metabolism 4 4.39 × 10–3 7 1.76 × 10–4
Steroid-hormone metabolism 2 1.79 × 10–1 4 1.96 × 10–3
aBonferroni corrected.Suvorov and Takser
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Discussion
To our knowledge, this is the first study 
of PBDE effects on a mammal using high-
throughput genomic methods. We obtained 
evidence of prolonged effects of perinatal 
exposure to low doses of BDE-47 on gene 
expression profile in the liver tissues of rat 
offspring. Significant 2-fold changes in gene 
expression were observed in pups 1 week after 
the last indirect (via milk) administration of 
BDE-47. The observed change in gene expres-
sion was dose dependent for the majority of 
altered genes. Multiple signaling and meta-
bolic pathways were affected by BDE-47 or 
its metabolites in our study.
The protocol of exposure used in this 
study was designed to simulate exposure of the 
general population. In contrast to most pub-
lished experimental studies of PBDE toxicity, 
we used an intravenous route of exposure for 
dams to assure the accuracy of internal dosing. 
As we used very low doses (the high dose used 
herein, 0.2 mg/kg BW, is among the lowest 
ever used in experimental studies), intravenous 
administration allowed avoiding uncertainty 
in the amount of BDE-47 received. In fact, 
the rat offspring studied in our experiments 
received BDE-47 via cord blood and via milk. 
As BDE-47 was previously detected in both 
human cord blood and milk (Frederiksen 
et al. 2009), the chosen route of administra-
tion has relevance for humans. The choice 
of doses in our study was verified by internal 
doses estimated earlier (Suvorov et al. 2008): 
BDE-47 concentrations in subcutaneous fat of 
the dams and pups 1 week after the last injec-
tion corresponds to the levels observed in the 
North American human population.
One of the major findings of the current 
study is the differential expression of phase I 
and II metabolic enzymes. This finding is sup-
ported by the enriched PANTHER molecu-
lar function categories (oxidoreductase and 
transferase) and biological process categories 
(electron transport) as well as the following 
significantly enriched canonical pathways 
according to IPA analysis: LPS/IL-1–mediated 
inhibition of retinoid X receptor (RXR) func-
tion; pregnane X receptor (PXR)/RXR activa-
tion; xenobiotic metabolism signaling; and 
metabolism of xenobiotics by cytochrome 
P450 (CYP). All these pathways overlap and 
partly describe the same cellular processes 
[see Supplementary Material (doi:10.1289/
ehp.0901031.S1)]. 
Because induction of cytochrome enzymes 
may alter numerous metabolic pathways 
and lead to the formation of oxygen radi-
cals and/or carcinogens, the study of hepatic-
enzyme induction has remained within the 
focus of experimental toxicology from the 
earliest PBDE studies. It has been demon-
strated that both the commercial mixtures 
and BDE-47 congener induced phase I 
EROD (ethoxyresorufin-O-deethylase) and 
PROD (pentoxyresorufin-O-deethylase) and 
phase II metabolic enzyme activity (uridine-
diphosphate-glucuronosyltransferase) (Carlson 
1980; Hallgren and Darnerud 1998; von 
Meyerinck et al. 1990; Zhou et al. 2001). 
In all these studies, however, the named 
induction was observed at levels of exposure 
exceeding many-fold environmental expo-
sures (ranging usually from tens to hundreds 
of milligrams per kilogram BW).
In a study by Sanders et al. (2005), liver 
expression of CYP1A1, CYP2B, and CYP3A 
were analyzed after oral administration of 
DE-71 as well as individual congeners to 
adult rats on 3 consecutive days in doses rang-
ing from 1.5 to 150 µmol/kg BW/day. The 
cytochromes chosen were biomarkers for acti-
vation of aryl hydrocarbon receptor (AhR), 
constitutive androstane receptor (CAR), and 
PXR. The authors concluded that PBDEs, 
being non-coplanar organohalogens, are very 
poor AhR inducers and that most of previ-
ously reported AhR-inducing properties of 
PBDE mixtures can be explained by the 
presence of polybrominated dibenzofurans 
(PBDF) and polybrominated dibenzo  dioxins 
(PBDD) in the mixtures. However, the sig-
nificant up-regulation of CYP2B and CYP3A 
by BDE-47 was also achieved at high doses of 
4.9 and 49 mg/kg BW/day, respectively.
Similar conclusions concerning the role 
of PBDD and PBDF in activating AhR by 
low-grade purified BDE-47 were reported by 
Wahl et al. (2008) based on a study of AhR-
mediated toxicity and gene expression in rat 
hepatoma cells and in zebrafish embryos. In 
addition, CYP2B and CYP3A were found to 
be overexpressed in this study. 
Pacyniak et al. (2007) found that CYP3A11 
and CYP2B10 (but not CYP1A1) were overex-
pressed in adult mice livers after 4 consecutive 
days of intraperitoneal injections of 10 and 
100 µmol of different congeners of PBDE (4.9 
and 49 mg/kg/ BW/day for BDE-47). Because 
the two induced cytochromes are known target 
genes of PXR, the authors conclude that PBDE 
congeners are PXR activators. This conclu-
sion was supported by luciferase assays, which 
showed that BDE-47, 99, and 209 activated 
PXR and its human counterpart, steroid X 
receptor, but not AhR.
Hence, the evidence obtained by several 
groups (Pacyniak et al. 2007; Sanders et al. 
2005; Wahl et al. 2008) supports the idea that 
PBDE induces CYP by a mechanism other 
than AhR mediation. At the same time, induc-
tion of CYPs that are targets for receptors other 
than AhR receptors were also observed at the 
high doses of PBDE exposure. 
According to our data, no CYPs were 
induced in the AhR pathway. Moreover, 
all three molecules, GSTM1, GSTA5 and 
ALDH9A1, differentially expressed down-
stream of AhR are also regulated through the 
CAR. It could be assumed, therefore, that 
AhR does not participate at all in PBDE-
induced response. 
Table 3. IPA generated canonical pathways significantly enriched in liver samples obtained from rats 
perinatally exposed to BDE-47. 
Ingenuity canonical pathways Log (BH p-value) Ratio Genes 
Signaling pathways
LPS/IL-1 mediated inhibition of  
RXR function
1.22 × 10–7 7.10 × 10–2 ALDH9A1, CYP2C, CYP2C7, CYP3A23, 
CYP4A1, CYP4A3, CYP7A1, GSTA5, 
GSTM1, SULT1B1
PXR/RXR activation 3.60 × 10–7 1.30 × 10–1 CYP2C, CYP2C7, CYP3A23, CYP7A1, 
G6PC, GSTM1, UGT1A1
Xenobiotic metabolism signaling 2.80 × 10–5 4.88 × 10–2 ALDH9A1, CYP2C, CYP2C7, CYP3A23, 
GSTA5, GSTM1, SULT1B1, UGT1A1
AhR signaling 1.10 × 10–2 3.88 × 10–2 GSTM1, NFIX, GSTA5, ALDH9A1
Metabolic pathways
Lipid metabolism
Fatty acid metabolism 7.33 × 10–6 9.10 × 10–2 ALDH9A1, CYP2C, CYP2C7, CYP3A23, 
CYP4A1, CYP4A3, SDS
Arachidonic acid metabolism 3.96 × 10–4 6.94 × 10–2 CYP2C, CYP2C7, CYP3A23, CYP4A11, 
CYP4A3
Bile acid biosynthesis 2.86 × 10–3 1.15 × 10–1 CYP3A23, CYP7A1, ALDH9A1
Linoleic acid metabolism 1.42 × 10–2 5.56 × 10–2 CYP2C, CYP3A23, CYP2C7
Metabolism of cofactors and vitamins
Metabolism of xenobiotics by CYP 2.80 × 10–5 8.10 × 10–2 CYP2C, CYP2C7, CYP3A23, GSTA5, 
GSTM1, UGT1A1
Carbohydrate metabolism
Glycolysis/gluconeogenesis 8.29 × 10–3 7.70 × 10–2 G6PC, LDHA, ALDH9A1
Propanoate metabolism 8.68 × 102 7.32 × 10–2 SDS, LDHA, ALDH9A1
Amino acid metabolism
Tryptophan metabolism 8.60 × 10–4 5.88 × 10–2 ALDH9A1, CYP2C, CYP2C7, CYP3A23, 
SDS
Cysteine metabolism 1.89 × 10–3 1.30 × 10–1 SDS, SULT1B1, LDHA
Metabolism of complex carbohydrates
Starch and sucrose metabolism 8.68 × 10–3 7.14 × 10–2 G6PC, UGT1A1, SLC3A2Gene expression analysis in rats exposed to BDE-47
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Six  CYPs  (CYP2C,  CYP2C7, 
CYP3A23/3a1, CYP4A1, CYP4A3, and 
CYP7A1) were 2-fold differentially expressed 
in our study (Table 3). According to current 
knowledge, these cytochromes are targets of 
several nuclear receptors. CAR may participate 
in the induction of CYP2C (Gerbal-Chaloin 
et al. 2002), CYP2C7 (Chen et al. 2003), and 
CYP3A23 (Sueyoshi and Negishi 2001). These 
three CYPs can be induced by PXR (Kliewer 
et al. 2002). CYP4A3 and CYP4A1 are known 
to be regulated by peroxisome proliferator-
activated receptor alpha (PPARα) (Kroetz 
et al. 1998). Finally, multiple mechanisms are 
involved in the control of CYP7A1 transcrip-
tion, and a variety of transcription factors and 
nuclear receptors participate in the sophisti-
cated regulatory networks (Gilardi et al. 2007), 
including PXR, liver X receptor alpha (LXRα), 
farnesoid X receptor, and CAR. The common 
feature of all these receptors is that they rep-
resent the dimerization partners for RXRs. In 
context of RXR pathway, a number of genes 
were significantly overexpressed at the smallest 
ever studied exposure doses of BDE-47, 0.002 
mg/kg BW. The direct interaction of PBDE 
with RXR or upstream mechanisms of RXR 
induction cannot be excluded in light of this 
evidence. The possibility of direct interaction 
of xenobiotics with RXRs was recently dem-
onstrated (Alsop et al. 2003; Li et al. 2008) as 
well as possibility of induction of PPAR and 
LXR pathways by RXR-selective ligands (le 
Maire et al. 2009; Mukherjee et al. 1997).
Regulation of several CYPs consistent with 
activation of PXR may affect concentrations 
of molecules important for the regulation of 
the physiological functions of an organism. 
Thus, according to the enriched PANTHER 
biological processes, steroid-hormone metab-
olism was altered in the rat offspring exposed 
to BDE-47. Two genes activated by PXR, 
CYP3A23 and UGT1A1, are involved in 
testosterone hydroxylation and glucuroni-
dation, respectively. These reactions result 
in products that are more polar, water solu-
ble, and more easily excreted from the body 
than the parent compound (Bélanger et al. 
2003). Increased testosterone excretion may 
be responsible for the impairment of sexual 
development observed in the PBDE-exposed 
rats, namely, decreased sperm count, femi-
nization of sexually dimorphic behavior, and 
decreased anogenital distance in rat male 
offspring (Kuriyama et al. 2005; Lilienthal 
et al. 2006). The anogenital distance was sig-
nificantly decreased on PND 66 in the male 
offspring exposed to 0.2 mg/kg BW BDE-47 
from the same litters studied herein (Suvorov 
and Takser 2008a).
Activation of PXR may be responsible 
as well for down-regulation of CYP7A1, the 
rate-limiting enzyme of bile-acid biosyn-
thesis from cholesterol, in G3. In G2, the 
same enzyme was slightly overexpressed. This 
nature of nonlinear dose–response expression 
of CYP7A1 is unclear and probably relates 
to the sophisticated network of receptors and 
transcription factors involved in its regulation 
(Gilardi et al. 2007). 
The next major finding consists of acti-
vation of a number of metabolic pathways, 
including metabolism of lipids, carbohy-
drates, and amino acids. In fact, up-regulation 
of glucose-6-phosphate phosphatase (G6PC) 
causes uptake of glucose and its retention in 
cytoplasm. Overexpression of G6PC corre-
sponds to the previously reported (Suvorov 
et al. 2009) observation of increased recov-
ery rate of blood glucose levels after oral glu-
cose administration in exposed rats compared 
with controls. SLC3A2, responsible for the 
starch hydrolysis with dextrin production, 
which hydrolyzes further into glucose, is 
overexpressed as well. Further, LOC500506 
is upregulated. This gene is similar to another 
key enzyme, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), which catalyzes 
the first reaction of the “payoff” phase of 
glycolysis. Two enzymes responsible for lac-
tate transformation into acetyl-CoA are up- 
regulated as well. Finally, alternative α and 
ω pathways of oxidation of fatty acids are 
activated in the exposed groups of rats (Table 
3). Alteration of carbohydrate metabolism 
genes, along with genes involved in proton 
transport, was shown recently in zebrafish 
embryonic fibroblasts after the treatment by 
6-hydroxy-2,2´,4,4´-BDE-47 (van Boxtel 
et al. 2008). Activation of metabolic pathways 
corresponds to our previous finding (Suvurov 
et al. 2009) of increased growth and elevated 
blood IGF-1 in rat offspring exposed to low 
doses BDE-47, using the same protocol as in 
the present study. In fact, IGF-1 and somato-
tropin are known to be powerful anabolism 
promoters (Scarth 2006). In this regard, it 
is interesting to mention that IGFBP2 was 
significantly overexpressed by 2-fold in liver 
of both groups of exposed rats. IGFBP-2 
demonstrates cell-surface localization, and it 
has been suggested that membrane-associated 
IGFBP-2 may concentrate the IGFs in close 
vicinity of their receptors, thereby increasing 
their mitogenic potential (Chesik et al. 2007).
Conclusion
This study has revealed an alteration in gene 
expression involved in the metabolic and sig-
naling pathways and functions of the organ-
ism after perinatal exposure of rat offspring to 
BDE-47 at doses relevant for general popula-
tion. This analysis, based on genomic meth-
ods, yielded new information that can be used 
for generating a mechanistic hypothesis for 
further study of perinatal exposure of PDBE 
using traditional methods of toxicology.
Figure 2. IPA generated canonical pathways enriched in the liver of rats exposed to BDE-47. Ratio, number 
of 2-fold differentially expressed genes that map to a pathway divided by the total number of genes in 
Illumina RatRef-12 annotation that map to the canonical pathway; p-value, probability that the association 
between the 2-fold differentially expressed genes and the canonical pathway can be accounted for by 
chance only.
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